Simon N.R. Harford insider trades: Albireo Pharma (ALBO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Simon reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | ALBO | ↓ Sell10b5-1 | 102 | $43.80 | $4K | Direct | Jan 23, 2023 (0d) |
| Jan 19, 2023 | ALBO | ↓ Sell10b5-1 | 1,776 | $43.80 | $78K | Direct | Jan 20, 2023 (1d) |
| Oct 24, 2022 | ALBO | ↓ Sell10b5-1 | 104 | $19.58 | $2K | Direct | Oct 25, 2022 (1d) |
| Oct 11, 2022 | ALBO | ↓ Sell10b5-1 | 80 | $23.79 | $2K | Direct | Oct 13, 2022 (2d) |
| Jul 22, 2022 | ALBO | ↓ Sell10b5-1 | 106 | $24.67 | $3K | Direct | Jul 25, 2022 (3d) |
| Jul 12, 2022 | ALBO | ↓ Sell10b5-1 | 95 | $24.03 | $2K | Direct | Jul 13, 2022 (1d) |
| Apr 22, 2022 | ALBO | ↓ Sell10b5-1 | 103 | $32.92 | $3K | Direct | Apr 25, 2022 (3d) |
| Apr 11, 2022 | ALBO | ↓ Sell10b5-1 | 96 | $35.74 | $3K | Direct | Apr 11, 2022 (0d) |
| Jan 24, 2022 | ALBO | ↓ Sell10b5-1 | 416 | $24.88 | $10K | Direct | Jan 25, 2022 (1d) |
| Jan 11, 2022 | ALBO | ↓ Sell10b5-1 | 111 | $25.95 | $3K | Direct | Jan 11, 2022 (0d) |
| Oct 11, 2021 | ALBO | ↓ Sell10b5-1 | 93 | $30.23 | $3K | Direct | Oct 12, 2021 (1d) |
| Jul 13, 2021 | ALBO | ↓ Sell10b5-1 | 98 | $35.02 | $3K | Direct | Jul 15, 2021 (2d) |
| Apr 12, 2021 | ALBO | ↓ Sell10b5-1 | 92 | $32.12 | $3K | Direct | Apr 14, 2021 (2d) |
| Jan 11, 2021 | ALBO | ↓ Sell | 110 | $37.33 | $4K | Direct | Jan 13, 2021 (2d) |
| Oct 12, 2020 | ALBO | ↓ Sell | 90 | $37.30 | $3K | Direct | Oct 13, 2020 (1d) |
| Jul 10, 2020 | ALBO | ↓ Sell | 92 | $25.56 | $2K | Direct | Jul 10, 2020 (0d) |
| Apr 13, 2020 | ALBO | ↓ Sell | 97 | $16.52 | $2K | Direct | Apr 13, 2020 (0d) |
| Jan 10, 2020 | ALBO | ↓ Sell | 105 | $27.20 | $3K | Direct | Jan 14, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Simon N.R. Harford's insider trades
Simon N.R. Harford is CFO and Treasurer at Albireo Pharma (ALBO). Since Jan 10, 2020, Simon has reported no open-market purchases and 18 sales worth $135K on SEC Form 4. There have been no open-market trades in the last 12 months.
13 sales (89% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (12 filings), shares withheld for taxes (4 filings), other transactions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALBO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.